Next Article in Journal / Special Issue
Prognosis of Early-Onset vs. Late-Onset Mild Cognitive Impairment: Comparison of Conversion Rates and Its Predictors
Previous Article in Journal
Advice for Elderly Drivers in a German Memory Clinic: A Case Report on Medical, Ethical and Legal Consequences
Previous Article in Special Issue
Current and Future Perspectives of Liaison Psychiatry Services: Relevance for Older People’s Care
Article Menu

Export Article

Open AccessArticle
Geriatrics 2016, 1(2), 10; doi:10.3390/geriatrics1020010

Potential Influence of Aspirin on Neopterin and Tryptophan Levels in Patients with a Delirium

1
Section of Geriatric Medicine, Department of Internal Medicine, Erasmus University Medical Center, ’s-Gravendijkwal 230, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
2
Department of Clinical Chemistry, Erasmus University Medical Center, ’s-Gravendijkwal 230, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
*
Author to whom correspondence should be addressed.
Academic Editor: Joaquim Cerejeira
Received: 26 October 2015 / Revised: 21 March 2016 / Accepted: 25 March 2016 / Published: 31 March 2016
(This article belongs to the Special Issue Medical Disorders and Cognition in the Elderly)
View Full-Text   |   Download PDF [446 KB, uploaded 31 March 2016]   |  

Abstract

In an in vitro study, it was found that aspirin might decrease neopterin production and tryptophan degradation. The aim of the present study was to evaluate the possible association between aspirin use and mean neopterin and tryptophan levels in patients with and without a delirium and whether the use of aspirin is associated with a decreased prevalence of delirium. Neopterin and tryptophan levels were determined previously in acutely ill admitted patients aged ≥65 years. The possible influence of aspirin on mean levels of neopterin and tryptophan was investigated with univariate analysis of variance in adjusted models. Eighty-three patients were included; 22 had a delirium. In patients without a delirium (no aspirin (n = 31) versus aspirin (n = 27)), mean neopterin levels were 47.0 nmol/L versus 43.6 nmol/L (p = 0.645) and tryptophan levels were 33.1 µmol/L versus 33.9 µmol/L (p = 0.816). In patients with a delirium (no aspirin (n = 13) versus aspirin (n = 9)), mean neopterin levels were 77.8 nmol/L versus 71.1 nmol/L (p = 0.779) and tryptophan levels were 22.4 µmol/L versus 27.3 µmol/L (p = 0.439). No difference was found in the distribution of aspirin users between patients with and without a delirium. In this study, we found that the use of aspirin had no significant effect on mean levels of neopterin and tryptophan. However, the raw data suggest that there might be a potential influence in patients with a delirium. Aspirin use was not associated with a decreased prevalence of delirium. View Full-Text
Keywords: delirium; neopterin; tryptophan; NSAIDs; aspirin delirium; neopterin; tryptophan; NSAIDs; aspirin
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Egberts, A.; Fekkes, D.; Ziere, G.; van der Cammen, T.J.M.; Mattace-Raso, F.U.S. Potential Influence of Aspirin on Neopterin and Tryptophan Levels in Patients with a Delirium. Geriatrics 2016, 1, 10.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Geriatrics EISSN 2308-3417 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top